AKRO - Akero Therapeutics, Inc.
54.65
0.100 0.183%
Share volume: 15,312,254
Last Updated: 12-08-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$54.55
0.10
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-09-2024 | 11-08-2024 | 02-28-2025 | 05-12-2025 | 08-08-2025 | 11-07-2025 | |
| Cash flow financing | 366.938 M | -150.000 K | 3.067 M | 75.991 M | 395.531 M | 3.433 M | -34.027 M | |
| Other financing cash flows | 1.769 M | 3.000 K | 3.131 M | 8.242 M | 7.396 M | 2.975 M | 3.371 M | |
| Cash flow | 389.647 M | -313.499 M | 5.710 M | 24.173 M | -154.316 M | 34.527 M | -44.417 M | |
| Net income | -53.344 M | -55.987 M | -72.705 M | -70.024 M | -70.725 M | -70.505 M | -81.566 M | |
| Depreciation | 1.000 K | 1.000 K | 1.000 K | 15.000 K | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 57.849 M | -255.896 M | 73.067 M | 15.272 M | -482.183 M | 79.340 M | 56.781 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 389.647 M | -313.499 M | 5.710 M | 24.173 M | -154.316 M | 34.527 M | -44.417 M |